TUMOR INFILTRATING LYMPHOCYTES
Clinical trials for TUMOR INFILTRATING LYMPHOCYTES explained in plain language.
Never miss a new study
Get alerted when new TUMOR INFILTRATING LYMPHOCYTES trials appear
Sign up with your email to follow new studies for TUMOR INFILTRATING LYMPHOCYTES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could your own immune cells beat advanced melanoma?
Disease control CompletedThis trial tested a new treatment called GC101 TIL for people with advanced melanoma that has not responded to standard therapies. The treatment uses immune cells taken from the patient's own tumor, grown in a lab, and then given back to the patient. The study enrolled 18 partici…
Matched conditions: TUMOR INFILTRATING LYMPHOCYTES
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Your own tumor cells could be the key to fighting cancer
Disease control CompletedThis early-phase trial tested a personalized immunotherapy for people with advanced solid tumors. Doctors removed a sample of each patient's tumor, grew the immune cells (TILs) in a lab, and then infused them back along with another drug. The goal was to see if this approach is s…
Matched conditions: TUMOR INFILTRATING LYMPHOCYTES
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC